Two equally rare diseases — Angelman and Prader-Willi syndrome — originate from the same genetic deletion, but lead…
Larry Luxner
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Larry Luxner
Genetic sequencing and the speed with which it can help diagnose a child’s disease — in addition to revealing the genes…
When it comes to rare diseases, one that definitely makes the list is spinal muscular atrophy with respiratory distress —…
In his 10 months on the job, Commissioner Scott Gottlieb of the U.S. Food and Drug Administration is earning…
At a time of unprecedented polarization in Congress, two U.S. lawmakers — one Republican, one Democrat — are stressing the urgency…
Retrophin and the U.S. subsidiary of Britain’s Horizon Pharma will each donate $3 million over a six-year period…
In recognition of Rare Disease Day 2018, Bionews Services — which publishes this website — will attend and…
FASTÂ has started a for-profit company to try to accelerate the development of a potential cutting-edge treatment for Angelman syndrome.
A rock-painting contest in Las Vegas. A fashion show in New York. A 7,000-meter race around the Washington Monument that’ll…
David Curtis Glebe, a retired 64-year-old public prosecutor now living in Millsboro, Delaware, knows he’s lucky to be alive. In…